Acumen Pharmaceuticals, Inc. (ABOS) vs ALX Oncology Holdings Inc. (ALXO)
A side-by-side comparison of Acumen Pharmaceuticals, Inc. and ALX Oncology Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABOS
Acumen Pharmaceuticals, Inc.
$2.13HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
ALXO
ALX Oncology Holdings Inc.
$1.21HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ABOS vs ALXO
growth of $100 · dividends reinvested · last 5yABOS -89.4% (-36.2%/yr)ALXO -97.8% (-53.3%/yr)ABOS compounded faster over this window
ABOS ALXO
ABOS vs ALXO: by the numbers
- •ALXO is the larger company ($163M vs $154M market cap).
Metrics side by side
Valuation
| Metric | ABOS | ALXO |
|---|---|---|
| P/B ratio | 2.69 | 1.20 |
Profitability
| Metric | ABOS | ALXO |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -183.44% | -59.40% |
| ROIC | -118.67% | -56.53% |
Growth (annualized)
| Metric | ABOS | ALXO |
|---|---|---|
| Total return CAGR (5Y) | -32.60% | -56.07% |
Frequently asked
- How have ABOS and ALXO total returns compared?
- Over the past 5 years, ABOS delivered -32.60% and ALXO delivered -56.07% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.